Luis-Emilio Garcia-Perez (Luis-Emilio García-Pérez)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Topics

Combination Therapy

Top Venues

Diabetes, obesity & metabolism

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Annabel Barrett, Kristina Secnik Boye, Luis-Emilio Garcia-Perez, Francesco Giorgino, Bruno Guerci, Martin Füchtenbusch, Maria Yu, Hélène Sapin, Anne Dib, Elke Heitmann, Marco Orsini Federici, Jérémie Lebrec
The real-world observational prospective study of health outcomes with dulaglutide and liraglutide in type 2 diabetes patients (TROPHIES): resource use and costs of treatment in clinical practice in France, Germany, and Italy. Journal of medical economics 27 (1) (2024)
Francesco Giorgino, Bruno Guerci, Martin Füchtenbusch, Jérémie Lebrec, Kristina Secnik Boye, Marco Orsini Federici, Elke Heitmann, Anne Dib, Maria Yu, Hélène Sapin, Luis-Emilio Garcia-Perez
The real-world observational prospective study of health outcomes with dulaglutide and liraglutide in patients with type 2 diabetes (TROPHIES): Final, 24-month analysis of time to first significant treatment change, treatment persistence and clinical outcomes. Diabetes, obesity & metabolism (2023)
Kristina S Boye, Jérémie Lebrec, Anne Dib, Elke Heitmann, Marco Orsini Federici, Maria Yu, Hélène Sapin, Annabel Barrett, Bruno Guerci, Francesco Giorgino, Martin Füchtenbusch, Luis-Emilio Garcia-Perez
The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Final patient-reported outcomes at 24 months. Diabetes, obesity & metabolism (2023)
Carel W le Roux, Emily R Hankosky, Duzhe Wang, Raleigh E Malik, Maria Yu, Ana Hickey, Hong Kan, Mathijs C Bunck, Adam Stefanski, Luis-Emilio Garcia-Perez, Sean Wharton
Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison. Diabetes, obesity & metabolism (2023)
Bruno Guerci, Francesco Giorgino, Hélène Sapin, Kristina Boye, Jérémie Lebrec, Marco Orsini Federici, Elke Heitmann, Anne Dib, Martin Füchtenbusch, Luis-Emilio Garcia-Perez
The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Patients with Type 2 Diabetes (TROPHIES): Patient disposition, clinical characteristics and treatment persistence at 12 months. Diabetes, obesity & metabolism 24 (12) (2022)
Esteban Jódar, Irene Romera, Qianqian Wang, Sarah Louise Roche, Luis-Emilio Garcia-Perez
Glycemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized, clinical trials. Diabetes, obesity & metabolism (2021)
Kristina S Boye, Matthew C Riddle, Ulagamadesan Venkatesan, Reema Mody, Luis-Emilio Garcia-Perez, Chrisanthi A Karanikas, Maureen J Lage, Jeffrey S Riesmeyer, Mark C Lakshmanan
Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States. Diabetes, obesity & metabolism 21 (6) (2019)
Louis S Matza, Kristina S Boye, Katie D Stewart, Karin S Coyne, Paula K Wullenweber, Katelyn N Cutts, Jessica B Jordan, Qianqian Wang, Maria Yu, Brooke M Currie, Karen G Malley, K Jack Ishak, Ryan T Hietpas, Luis-Emilio Garcia-Perez
Assessing patient PREFERence between the dulaglutide pen and the semaglutide pen: A crossover study (PREFER). Diabetes, obesity & metabolism 22 (3) (2019)
Francesco Giorgino, Maria Yu, Axel Haupt, Zvonko Milicevic, Luis-Emilio Garcia-Perez
Effect of once-weekly dulaglutide versus insulin glargine in people with type 2 diabetes and different baseline glycaemic patterns: A post hoc analysis of the AWARD-2 clinical trial. Diabetes, obesity & metabolism 21 (11) (2019)
Chantal Mathieu, Stephano Del Prato, Fady T Botros, Vivian T Thieu, Imre Pavo, Nan Jia, Axel Haupt, Chrisanthi A Karanikas, Luis-Emilio Garcia-Perez
Effect of once weekly dulaglutide by baseline beta-cell function in people with type 2 diabetes in the AWARD programme. Diabetes, obesity & metabolism 20 (8) (2018)
Baptist Gallwitz, Samuel Dagogo-Jack, Vivian Thieu, Luis-Emilio Garcia-Perez, Imre Pavo, Maria Yu, Kenneth E Robertson, Nan Zhang, Francesco Giorgino
Effect of once-weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c. Diabetes, obesity & metabolism 20 (2) (2017)